Ribbon Biolabs Reaches Key Milestone with Automation of InfiniSynthTM Platform for Commercial-scale, Unlimited Length DNA Synthesis

Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynthTM platform for the automated assembly of sequence-agnostic and long DNA. Ribbon

Related Keywords

Brianj Osullivan ,Marcj Brehme ,Kostenloser Wertpapierhandel ,Gabriele Schaller ,Biolabs Gmb ,Kevin Wp Miller ,Highres Biosolutions ,Pr Communications ,Ribbon Biolabs ,Technology Officer ,Senior Vice President ,Site Acceptance ,Ribbon Biolab Series ,Res Biosolutions ,Biolabs Gmbh ,Marketing Scientific Engagement ,Ribbon ,Biolabs ,Beaches ,Milestone ,Utomation ,Nfinisynthtm ,Platform ,Commercial ,Scale ,Enlimited ,Length ,Synthesis ,